PRISMMEDI (PRISMMEDI) Fair Value & Analysis

IN · Market cap ₹169M

P PRISMMEDI PRISMMEDI · BSE

Price₹27.86

Fair Value₹7.96

Upside-71.4%

Quality71/100

Watch PRISMMEDI for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range ₹5.57 – ₹10.35

Fair value as of: Jul 5, 2026

From 20 valuation models · updated today

Share price −3.9% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹12.83 – ₹33.90 · fair‑value band ₹5.57 – ₹10.35 · the ₹27.86 price screens above the ₹7.96 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

PRISMMEDI (PRISMMEDI) currently trades at ₹27.86, while our model-based Fair Value estimate is ₹7.96 — implying the stock looks roughly 71.4% overvalued today. We read business quality at 71/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, PRISMMEDI generated revenue of ₹24.4M at a net margin of 13.0%. Revenue grew 286.5% year over year. It earns a return on equity of 2.1%. Net debt stands at ₹18.6M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹5.57 (bear case) to ₹10.35 (bull case); at ₹27.86, the current price sits above that range. The share trades about 19% below its 52-week high and 123% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹24.4M

Revenue growth (YoY) +287%

Net margin 13.0%

Return on equity 2.1%

Free cash flow ₹17.0K FY2026

P/E ratio 2,786.0

More key figures

Operating margin -43.6%

EPS (TTM) ₹0.0100

Net debt ₹18.6M FY2019

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

PRISMMEDI reported revenue of ₹24.4M in FY2026 versus ₹84.4M in FY2022, a compound −26.7%/yr. Reported net income was ₹3.2M in FY2026.

Revenue −26.7%/yr

FY22 ₹84.4M

FY23 ₹12.7M

FY24 ₹29.3M

FY25 ₹6.3M

FY26 ₹24.4M

Net income

FY22 −₹3.7M

FY23 −₹763K

FY24 −₹214K

FY25 −₹487K

FY26 ₹3.2M

Is PRISMMEDI fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

PRISMMEDI · Fair Value
₹7.96 −71%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/PRISMMEDI" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">PRISMMEDI · Fair Value</span><br><b style="font-size:20px">₹7.96</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−71%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "PRISMMEDI Fair Value". https://www.fairvalue-calculator.com/stock/PRISMMEDI

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is PRISMMEDI (PRISMMEDI) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹7.96 versus a price of ₹27.86 — about −71% (overvalued). Model-based estimate, not financial advice.

What is the fair value of PRISMMEDI?

Our model-based fair value for PRISMMEDI is ₹7.96 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹27.86.

What is the quality score of PRISMMEDI?

PRISMMEDI has a Quality Score of 71/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of PRISMMEDI (PRISMMEDI)?

PRISMMEDI reported trailing-twelve-month revenue of about ₹24.4M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of PRISMMEDI?

The net profit margin of PRISMMEDI is about 13.0%, meaning it keeps roughly 13.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.